Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Peloton Therapeutics
Biotech
Chasing Merck, Arrowhead posts early data on anti-cancer RNAi
The readout provides preliminary evidence that ARO-HIF2 lowers levels of its target protein, encouraging Arrowhead to continue its pursuit of Merck.
Nick Paul Taylor
Jul 7, 2021 9:00am
Skyhawk Therapeutics names Peloton exec VP of oncology biology
Jul 8, 2019 10:48am
Merck boosts late-phase cancer pipeline with $1.1B Peloton buy
May 21, 2019 8:30am
